CA Patent

CA2720108A1 — Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

Assigned to Assertio Holdings Inc · Expires 2009-09-17 · 17y expired

What this patent protects

Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract ("G1&#3…

USPTO Abstract

Compositions and methods for the treatment of pain in a mammal are described. More specifically, a dosage form designed for release of acetaminophen and an opioid is described, wherein the dosage form provides delivery of the drugs to the upper gastrointestinal tract ("G1") of a mammal for an extended period of time

Drugs covered by this patent

Patent Metadata

Patent number
CA2720108A1
Jurisdiction
CA
Classification
—
Expires
2009-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Assertio Holdings Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.